Savara
SVRA
#5698
Rank
NZ$2.07 B
Marketcap
NZ$10.22
Share price
-2.00%
Change (1 day)
86.07%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -NZ$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$0.17 Billion a decrease over its 2023 earnings that were of -NZ$95.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.2 Billion19.69%
2024 -NZ$0.17 Billion75.29%
2023 -NZ$95.03 Million43.38%
2022 -NZ$66.28 Million-11.31%
2021 -NZ$74.73 Million-13.3%
2020 -NZ$86.2 Million-36.53%
2019 -NZ$0.14 Billion13.76%
2018 -NZ$0.12 Billion105.54%
2017 -NZ$58.09 Million34.11%
2016 -NZ$43.31 Million-37.43%
2015 -NZ$69.22 Million38.81%
2014 -NZ$49.87 Million33.62%
2013 -NZ$37.32 Million38.49%
2012 -NZ$26.95 Million24.59%
2011 -NZ$21.63 Million-36.5%
2010 -NZ$34.06 Million-3.14%
2009 -NZ$35.17 Million-23.28%
2008 -NZ$45.84 Million8.52%
2007 -NZ$42.24 Million-34.14%
2006 -NZ$64.14 Million184.43%
2005 -NZ$22.55 Million90.75%
2004 -NZ$11.83 Million190.35%
2003 -NZ$4.08 Million11.64%
2002 -NZ$3.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.55 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA